These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


893 related items for PubMed ID: 22156468

  • 1. BRAF mutation testing of thyroid fine-needle aspiration specimens enhances the predictability of malignancy in thyroid follicular lesions of undetermined significance.
    Adeniran AJ, Hui P, Chhieng DC, Prasad ML, Schofield K, Theoharis C.
    Acta Cytol; 2011; 55(6):570-5. PubMed ID: 22156468
    [Abstract] [Full Text] [Related]

  • 2. Different qualifiers of AUS/FLUS thyroid FNA have distinct BRAF, RAS, RET/PTC, and PAX8/PPARg alterations.
    Bellevicine C, Sgariglia R, Migliatico I, Vigliar E, D'Anna M, Nacchio MA, Serra N, Malapelle U, Bongiovanni M, Troncone G.
    Cancer Cytopathol; 2018 May; 126(5):317-325. PubMed ID: 29469940
    [Abstract] [Full Text] [Related]

  • 3. Pilot of BRAF mutation analysis in indeterminate, suspicious and malignant thyroid FNA cytology.
    Johnson SJ, Hardy SA, Roberts C, Bourn D, Mallick U, Perros P.
    Cytopathology; 2014 Jun; 25(3):146-54. PubMed ID: 24417615
    [Abstract] [Full Text] [Related]

  • 4. The prediction of malignant risk in the category "atypia of undetermined significance/follicular lesion of undetermined significance" of the Bethesda System for Reporting Thyroid Cytopathology using subcategorization and BRAF mutation results.
    Hyeon J, Ahn S, Shin JH, Oh YL.
    Cancer Cytopathol; 2014 May; 122(5):368-76. PubMed ID: 24591408
    [Abstract] [Full Text] [Related]

  • 5. The Combined Use of Fine-Needle Aspiration (FNA) and BRAF V600E Gene Testing: Can it Increase the Definitive Diagnosis Rate of Nodules Categorized as Bethesda III for Papillary Thyroid Carcinoma?
    Lei L, Hong Qing S, Wei L, Ma Mo Yang F, Xiao Xiang Y.
    Am Surg; 2024 Dec; 90(12):3209-3215. PubMed ID: 39047144
    [Abstract] [Full Text] [Related]

  • 6. BRAF mutation detection in indeterminate thyroid cytology specimens: underlying cytologic, molecular, and pathologic characteristics of papillary thyroid carcinoma.
    Ohori NP, Singhal R, Nikiforova MN, Yip L, Schoedel KE, Coyne C, McCoy KL, LeBeau SO, Hodak SP, Carty SE, Nikiforov YE.
    Cancer Cytopathol; 2013 Apr; 121(4):197-205. PubMed ID: 22887810
    [Abstract] [Full Text] [Related]

  • 7. Reproducibility of atypia of undetermined significance/follicular lesion of undetermined significance category using the bethesda system for reporting thyroid cytology when reviewing slides from different institutions: A study of interobserver variability among cytopathologists.
    Padmanabhan V, Marshall CB, Akdas Barkan G, Ghofrani M, Laser A, Tolgay Ocal I, David Sturgis C, Souers R, Kurtycz DF.
    Diagn Cytopathol; 2017 May; 45(5):399-405. PubMed ID: 28217980
    [Abstract] [Full Text] [Related]

  • 8. Utility of BRAF mutation detection in fine-needle aspiration biopsy samples read as "suspicious for papillary thyroid carcinoma".
    Jara SM, Bhatnagar R, Guan H, Gocke CD, Ali SZ, Tufano RP.
    Head Neck; 2015 Dec; 37(12):1788-93. PubMed ID: 24989827
    [Abstract] [Full Text] [Related]

  • 9. BRAF mutation analysis of fine-needle aspiration biopsies of papillary thyroid carcinoma: impact on diagnosis and prognosis.
    Colanta A, Lin O, Tafe L, Ghossein R, Nafa K, Mitchell T, Ladanyi M, Arcila M.
    Acta Cytol; 2011 Dec; 55(6):563-9. PubMed ID: 22156467
    [Abstract] [Full Text] [Related]

  • 10. False-negative BRAF V600E mutation results on fine-needle aspiration cytology of papillary thyroid carcinoma.
    Paek SH, Kim BS, Kang KH, Kim HS.
    World J Surg Oncol; 2017 Nov 13; 15(1):202. PubMed ID: 29132392
    [Abstract] [Full Text] [Related]

  • 11. Detection of BRAF c.1799T > A (p.V600E) mutation using residual routine fine-needle aspiration specimens of papillary thyroid carcinoma.
    Zhao H, Zhang ZH, Zhou B, Xiao T, Pan QJ, Guo HQ.
    Diagn Cytopathol; 2015 Oct 13; 43(10):786-90. PubMed ID: 26152656
    [Abstract] [Full Text] [Related]

  • 12. Follow-up of atypia and follicular lesions of undetermined significance in thyroid fine needle aspiration cytology.
    Dincer N, Balci S, Yazgan A, Guney G, Ersoy R, Cakir B, Guler G.
    Cytopathology; 2013 Dec 13; 24(6):385-90. PubMed ID: 23078633
    [Abstract] [Full Text] [Related]

  • 13. Significance of Subcategory Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance Showing Both Cytologic and Architectural Atypia in Thyroid Aspiration Cytology.
    Jung YY, Jung S, Lee HW, Oh YL.
    Acta Cytol; 2015 Dec 13; 59(5):370-6. PubMed ID: 26529329
    [Abstract] [Full Text] [Related]

  • 14. Allele-specific PCR with competitive probe blocking for sensitive and specific detection of BRAF V600E in thyroid fine-needle aspiration specimens.
    Smith GD, Zhou L, Rowe LR, Jarboe EA, Collins BT, Bentz JS, Wittwer CT, Chadwick BE.
    Acta Cytol; 2011 Dec 13; 55(6):576-83. PubMed ID: 22156469
    [Abstract] [Full Text] [Related]

  • 15. Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in BRAF600E mutation-prevalent area.
    Chung KW, Yang SK, Lee GK, Kim EY, Kwon S, Lee SH, Park DJ, Lee HS, Cho BY, Lee ES, Kim SW.
    Clin Endocrinol (Oxf); 2006 Nov 13; 65(5):660-6. PubMed ID: 17054470
    [Abstract] [Full Text] [Related]

  • 16. Correlation Between Histological Diagnosis and Mutational Panel Testing of Thyroid Nodules: A Two-Year Institutional Experience.
    Shrestha RT, Evasovich MR, Amin K, Radulescu A, Sanghvi TS, Nelson AC, Shahi M, Burmeister LA.
    Thyroid; 2016 Aug 13; 26(8):1068-76. PubMed ID: 27283257
    [Abstract] [Full Text] [Related]

  • 17. Risk of Malignancy and Risk of Neoplasia in the Bethesda Indeterminate Categories: Study on 4,532 Thyroid Fine-Needle Aspirations from a Single Institution in India.
    Mahajan S, Srinivasan R, Rajwanshi A, Radotra B, Panda N, Dey P, Gupta N, Nijhawan R.
    Acta Cytol; 2017 Aug 13; 61(2):103-110. PubMed ID: 28407624
    [Abstract] [Full Text] [Related]

  • 18. Diagnostic Accuracy of Fine Needle Aspiration in Thyroid Nodules Arising in Patients with Graves Disease.
    Hang JF, Lilo MT, Bishop JA, Ali SZ.
    Acta Cytol; 2017 Aug 13; 61(2):117-124. PubMed ID: 28259878
    [Abstract] [Full Text] [Related]

  • 19. Cytologic features of focal papillary thyroid carcinoma arising within follicular adenoma: a masked cytomorphologic analysis of 17 cases.
    Ono JC, Wilbur DC, Lee H, Yang J, Krane JF, Bongiovanni M, Faquin WC.
    Acta Cytol; 2011 Aug 13; 55(6):531-8. PubMed ID: 22156462
    [Abstract] [Full Text] [Related]

  • 20. Use of BRAF v600e immunocytochemistry on FNA direct smears of papillary thyroid carcinoma.
    Wobker SE, Kim LT, Hackman TG, Dodd LG.
    Cancer Cytopathol; 2015 Sep 13; 123(9):531-9. PubMed ID: 26080065
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 45.